New Paradigms in Heart Failure: RAAS Inhibition and the Management of Hyperkalemia
ESC Congress 2015 – London, United Kingdom
Saturday, August 29, 2015
During this live educational program moderated by Professor John McMurray, new options for the treatment of hyperkalemia in heart failure patients will be presented. Dr. Faiez Zannad, a world leader on this topic, will lead the discussion with current challenges in optimizing renin-angiotensin-aldosterone inhibitors (RAASi) and Dr. Ileana Piña will provide pragmatic advice on new pharmacological treatment options for RAASi. This exciting program will offer attendees new ideas for consideration to achieve better outcomes.